According to the research report titled ‘North America Apheresis Equipment Market Size by Product, Application, Procedure, Technology, Industry Analysis Report, Regional Outlook, Application Potential, Competitive Market Share & Forecast, 2020 – 2026’, available with Market Study Report, North America apheresis equipment market is expected to surpass USD 2 billion by the year 2026.
 

High occurrence of blood diseases has enhanced the demand for high quality blood and blood products, which in turn is a major factor driving the apheresis equipment market growth in North America.  
 

Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/2683089/
 

For those unfamiliar, apheresis is a blood processing method which is used for treating various clinical conditions. It is primarily used for separating blood into plasma components, platelets, red blood cells and white blood cells.
 

Advancements in technology have allowed for development of automated apheresis equipment, thereby aiding the market expansion. These advanced devices help in reducing human intervention by integrating screen navigation, graphical user interface displays and automated operations.
 

Apart from this, strict regulatory scenario which ensures effective treatment methods are stimulating the industry outlook in North America. However, rising concerns regarding the complications associated with apheresis equipment may act as a inhibiting factor to the overall market.
 

Speaking of product type, the report cites that apheresis machines market segment is anticipated to showcase a y-o-y growth rate of 10.5% between 2020 and 2026. These machines are extensively utilized in blood transfusion processes. Besides this, technological breakthroughs are fueling the segmental growth.
 

Based on application landscape, the renal disease segment was worth USD 140 million in the year 2019 and is expected to register consistent growth during the forecast period. Rising adoption of apheresis equipment while treating renal diseases coupled with increased pervasiveness of chronic conditions are favoring the market outlook in North America.
 

Moving on to procedure type, the report claims that photopheresis segment held 22% market share in the year 2019 and is slated to witness commendable growth in the ensuing years. Increasing number of organ transplantations along with mounting cases of organ rejections have increased the demand for photopheresis procedures, thereby facilitating the overall business scenario.
 

In terms of technology, centrifugation segment generated revenues worth USD 480.5 million in the year 2019, owing to high consumer preferences towards separating plasma proteins from blood efficiently. In addition, rising adoption of centrifugation technology since it offers cellular therapies is augmenting the growth of the segment.
 

Considering the geographical landscape, apheresis equipment market in Canada is predicted to expand with a CAGR of 10.5% between 2020 and 2026. Increasing cases of chronic kidney diseases and rising number of transfusion services are swaying the business dynamics in Canada.
 

The competitive landscape of North America apheresis equipment market is defined by players such as Therakos, Inc., HemaCare Corp., Terumo BCT Inc., Haemonetics Corporation, Cerus Corporation, Fresenius SE & Co. KGaA, Asahi Kasei Corporation, and B. Braun Melsungen AG among others.